Latest Ratings for APLS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Goldman Sachs | Maintains | Buy | |
| Mar 2022 | Raymond James | Maintains | Strong Buy | |
| Jan 2022 | Raymond James | Maintains | Strong Buy |
Analyst Expectations For Apellis Pharmaceuticals’s Future
Where Today's News Shapes Tomorrow
